BIOXCEL THERAPEUTICS, INC. : Regulation FD Disclosure (form 8-K)

Item 7.01. Regulation FD Disclosure.

BioXcel Therapeutics, Inc. ("BTI") will be participating in various upcoming meetings with investors and analysts. A copy of the BTI's presentation materials that will be used at these meetings is available through the "Investors" page of the BTI website at http://www.bioxceltherapeutics.com.

The information in this Current Report on Form 8-K shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that Section, nor shall it be deemed to be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Exchange Act, except as expressly set forth by specific reference in such filing.

© Edgar Online, source Glimpses